| ID Source | ID |
|---|---|
| PubMed CID | 104008 |
| SCHEMBL ID | 25531 |
| MeSH ID | M0067724 |
| Synonym |
|---|
| dansylaziridine |
| 5E6272B7-5695-44E4-A4E4-9854C32078F0 |
| aziridine, n-dansyl- |
| 51908-46-4 |
| 5-(aziridin-1-ylsulfonyl)-n,n-dimethylnaphthalen-1-amine |
| A828847 |
| 5-(aziridin-1-ylsulfonyl)-n,n-dimethyl-naphthalen-1-amine |
| aziridine, 1-((5-(dimethylamino)-1-naphthalenyl)sulfonyl)- |
| unii-s4v8gq9xr2 |
| einecs 257-508-2 |
| 1-((5-(dimethylamino)-1-naphthyl)sulphonyl)aziridine |
| s4v8gq9xr2 , |
| FT-0620363 |
| SCHEMBL25531 |
| 5-dimethylaminonaphthalene-1-sulfonyl aziridine |
| AKOS024386268 |
| 5-(1-aziridinylsulfonyl)-n,n-dimethyl-1-naphthalenamine |
| DTXSID50199872 |
| 1-naphthalenamine, 5-(1-aziridinylsulfonyl)-n,n-dimethyl- |
| 5-(aziridine-1-sulfonyl)-n,n-dimethylnaphthalen-1-amine |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 12 (63.16) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 20 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||